-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Omega Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2020 to 2023.
- Omega Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$16.3M, a 45.1% increase year-over-year.
- Omega Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$78.9M, a 29.3% increase year-over-year.
- Omega Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$97.4M, a 5.13% increase from 2022.
- Omega Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$103M, a 50.4% decline from 2021.
- Omega Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$68.3M, a 132% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)